Many of us are far too familiar with the term “arthritis.” Well, so are many of our dogs. The arthritis most of our dogs get is known as osteoarthritis, or OA. It is a challenging disease involving ...

Cytopoint injection costs vary based on the size of your dog but can run anywhere from $50 to $200 or more. Cytopoint is a long-lasting, injectable treatment for dogs suffering from itchy, inflamed ...

PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced that the U.S. Food and Drug Administration (FDA) has approved Librela™ (bedinvetmab injection) for the control of pain ...

First long-acting canine anti-nerve growth factor monoclonal antibody therapy administered once every three months Approval marks major milestone in the company’s continued innovation for canine OA ...

SILVER SPRING, Md., Nov. 16, 2020 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Stelfonta (tigilanol tiglate injection) to treat dogs with non-metastatic, skin-based (cutaneous ...

The Humane Society Serving Clark County has switched from using carbon monoxide gas to euthanize dogs in its shelter to a lethal injection method. The local shelter recently made the move to lethal ...

The Veterinary Medicines Directorate has issued a product defect alert for four products by Dechra Pharmaceuticals PLC. Dechra is a global specialist in veterinary pharmaceuticals. The reason for the ...

Canine OA is a painful and progressive disease that is highly prevalent. In studies, 40% of dogs have signs of OA. 3,4 With an estimated 86 million dogs living in the U.S. households, a high ...

Today, the U.S. Food and Drug Administration approved Stelfonta (tigilanol tiglate injection) to treat dogs with non-metastatic, skin-based (cutaneous) mast cell tumors (MCTs). The FDA is also ...

First long-acting canine anti-nerve growth factor monoclonal antibody therapy administered once every three months Approval marks major milestone in the company’s continued innovation for canine OA ...